Skip to content

Health systems, not family factors, most crucial in PMTCT outcomes, Kenyan study shows

For women, HIV treatment based on atazanavir/ritonavir involves twice the risk of failure compared to efavirenz-containing therapy

Long-term suppression of viral load and sustained CD4 cell increase reduce risk of cervical HPV infection for HIV-positive women

HIV and TB in Practice for nurses: Pregnancy and TB/HIV

Pregnancy does not increase risk of nevirapine side-effects

Point-of-care (POC) diagnostics are essential to achieving an AIDS-free generation and improving outcomes in HIV-exposed children

New fixed-dose combination pills measure up to Atripla - corrected version*

Lack of understanding of treatment benefits may discourage women with HIV from having children – and could increase the risk of vertical transmission

Adverse birth outcomes more frequent in women exposed to ART during pregnancy, largest-ever study confirms